Proteasome inhibitor MG-132 enhances the expression of interleukin-6 in human umbilical vein endothelial cells: Involvement of MAP/ERK kinase. [electronic resource]
Producer: 20030110Description: 226-30 p. digitalISSN:- 0818-9641
- Butadienes -- pharmacology
- Cells, Cultured
- Cysteine Endopeptidases
- Cysteine Proteinase Inhibitors -- pharmacology
- Dactinomycin -- pharmacology
- Endothelium, Vascular -- drug effects
- Humans
- I-kappa B Proteins -- analysis
- Interleukin-6 -- biosynthesis
- Leupeptins -- pharmacology
- MAP Kinase Kinase Kinase 1
- Mitogen-Activated Protein Kinase Kinases -- immunology
- Multienzyme Complexes -- antagonists & inhibitors
- Nitriles -- pharmacology
- Proteasome Endopeptidase Complex
- Protein Serine-Threonine Kinases -- metabolism
- Umbilical Veins -- cytology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.